Arbutus Biopharma (ABUS) Interest Coverage Ratio (QoQ) (2014 - 2026)
Arbutus Biopharma (ABUS) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,147.70% |
| Dec 31, 2025 | 97.47% |
| Sep 30, 2025 | -808.43% |
| Jun 30, 2025 | 105.79% |
| Mar 31, 2025 | -97.62% |
| Dec 31, 2024 | 37.18% |
| Sep 30, 2024 | -232.27% |
| Jun 30, 2024 | -93.05% |
| Mar 31, 2024 | 75.56% |
| Dec 31, 2023 | -0.61% |
| Sep 30, 2023 | -335.90% |
| Jun 30, 2023 | -22.25% |
| Mar 31, 2023 | -402.48% |
| Dec 31, 2022 | 170.03% |
| Sep 30, 2022 | -41.83% |
| Jun 30, 2022 | -34.97% |
| Mar 31, 2022 | -271.76% |
| Dec 31, 2021 | 152.27% |
| Sep 30, 2021 | 1.13% |
| Jun 30, 2021 | -20.32% |